AGOS
LIVE

Serial Number

88718586

Owner

Agos Healthcare Limited

Attorney

RICHARD M. LABARGE

Filing Date

Dec 6, 2019

Add to watchlist:

No watchlists yet
View on USPTO

AGOS Trademark

Serial Number: 88718586 • Registration: 6344572

AGOS is a trademark filed by Agos Healthcare Limited on December 6, 2019. The trademark is classified under Class 9 (Computers & Electronics), Class 38 (Telecommunications), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Agos Healthcare Limited (3 trademarks)

Hitchin SG53AN , GB

Entity Type: 99

Trademark Details

Filing Date

December 6, 2019

Registration Date

May 11, 2021

Published for Opposition

February 23, 2021

Goods & Services

Downloadable and recorded computer software for use as a database and for analysing data in the fields of pharmaceuticals, clinical trials, clinical research and biotechnology; Downloadable software applications for computers, laptops and mobile phones featuring software for use as a database and for collating, storing, analysing, and utilizing data in the fields of pharmaceuticals, clinical trials, clinical research and biotechnology; Downloadable and recorded software for secure data storage and retrieval and transmission of customer and client information; Downloadable and recorded computer software for use as a database and for collating, storing, analysing and utilizing data in the field of pharmaceuticals, clinical trials, clinical research and biotechnology; downloadable and recorded computer operating programs and downloadable and recorded application development software for use on or in connection with mobile phones, tablets and handheld devices in the field of pharmaceuticals, clinical trials, clinical research and biotechnology; data processing equipment and computers; Downloadable electronic publications in the nature of e-books, magazines, newsletters and reports provided on-line from a database or the internet in the fields of pharmaceuticals, clinical trials, clinical research and biotechnology

Providing Internet access, namely, providing access to platforms and portals on the internet in the field of pharmaceuticals, clinical trials, clinical research and biotechnology; providing user access to global computer networks, namely, providing user access to platforms and portals on the internet in the field of pharmaceuticals, clinical trials, clinical research and biotechnology; information, advice and consultancy services in relation to all the aforesaid services

Business project and risk management services in the field of pharmaceuticals, clinical trials, clinical research and biotechnology; business consultancy services; Business project and risk management and consultancy services in the field of clinical trials and clinical research; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management services for medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; providing business information management services on clinical trials and clinical research; providing business intelligence services in the fields of medical devices, pharmaceuticals and the life sciences; providing business management information in connection with consultancy and advisory services in the field of strategic planning; regulatory submission management, namely, business strategic planning, and preparing and submitting applications for others for new medical devices, new pharmaceuticals, variations on previously approved medical devices, and variations on previously approved pharmaceuticals to receive clinical trial approval or marketing authorization from governmental regulatory bodies; regulatory submission management, namely, assisting others with strategic business planning, and preparing and filing applications with governmental regulatory bodies for approval of new medical devices and new pharmaceuticals; Regulatory submission management, namely, assisting others in preparing and filing applications for new drugs with governmental regulatory bodies; New pharmaceutical and biotechnology product commercialization services; consultancy services for others in the field of new pharmaceutical and biotechnology product commercialization; information, advice and consultancy services in relation to all the aforesaid services

Managed healthcare services being medical services in the field of pharmaceuticals, clinical trials, clinical research and biotechnology; consultancy services in the field of medical information services; medical consultancy services in the field of pharmaceuticals, clinical trials, clinical research and biotechnology; consultancy services in the field of biotechnology diagnostics and pharmacogenetics diagnostics medical testing; medical information, advice and consultancy services in the pharmaceutical and healthcare sectors; medical information, advice and consultancy services in relation to pharmacovigilance; information, advice and consultancy services in relation to all the aforesaid services

Providing medical and scientific research information in the field of pharmaceuticals, clinical trials, clinical research and biotechnology; Product and scientific research and development in the field of pharmaceuticals, clinical trials, clinical research, medical devices and biotechnology; Consultancy services for others in the field of technical consultancy for pharmaceuticals, design, planning, and implementation consultancy for clinical trials, consultancy on scientific clinical research, and design and development consultancy for medical devices; conducting early evaluations in the field of new pharmaceuticals; consultancy services in the field of design, planning, implementation and project management of clinical trials, pharmacovigilance, pharmaceutical and biotechnology product development; consultancy services in the fields of biotechnology, pharmaceutical research and development, laboratory testing and pharmacogenetics; medical and scientific research; conducting clinical trials for others; pharmaceutical drug development services; development of pharmaceutical preparations and medicines; pharmaceutical product evaluation; pharmaceutical research and development; product development consultancy in the field of pharmaceuticals and biotechnology; testing and quality control evaluation of products in the field of pharmaceuticals, clinical trials and biotechnology; product testing and quality control evaluation of pharmaceutical preparations and medicines; testing and quality control in the nature of conducting clinical trials in the field of pharmaceuticals and biotechnology for others; Software as a Service (SaaS) featuring software for use as a database and for analysing data in the fields of in the field of pharmaceuticals, clinical trials, clinical research and biotechnology; providing online non-downloadable software applications for use in creating, designing, hosting, publishing, managing and maintaining content for use on the internet for website and media content management purposes; application service provider featuring application programming interface (API) software to allow people to view data through an interactive map, to query data, to generate reports and to access data and documents; software as a service (SAAS) featuring computer software to enable the displaying, receiving and transmitting of data to enable the purchase of goods and services; information, advice and consultancy services in relation to all the aforesaid services

Filing History

REGISTERED-PRINCIPAL REGISTER
May 11, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 23, 2021 NPUB
PUBLISHED FOR OPPOSITION
Feb 23, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 3, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 21, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 21, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 21, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 21, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 21, 2021 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 19, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 19, 2021 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jan 19, 2021 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 26, 2020 GNFN
FINAL REFUSAL E-MAILED
Oct 26, 2020 GNFR
FINAL REFUSAL WRITTEN
Oct 26, 2020 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 20, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 20, 2020 CRFA
ASSIGNED TO LIE
Oct 19, 2020 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 3, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 9, 2020 GNRN
NON-FINAL ACTION E-MAILED
Mar 9, 2020 GNRT
NON-FINAL ACTION WRITTEN
Mar 9, 2020 CNRT
ASSIGNED TO EXAMINER
Mar 6, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 11, 2019 NWOS
NEW APPLICATION ENTERED
Dec 10, 2019 NWAP